Equity Profile

TMO

Thermo Fisher Scientific Inc.

Health CareLife Sciences Tools & Services$175.7B

Jul22Wed

Pre-Earnings Brief

UpcomingQ2-2026Pre-Market9:00 AM EDT

Company Snapshot

Thermo Fisher Scientific Inc. is a leading provider of scientific instruments and reagents used in laboratories and research facilities....

Key Metrics to Watch

Earnings Per Share (EPS)

EPS is a key indicator of profitability and will show how well the company is managing its costs and generating income.

N/A

Revenue Growth

Revenue growth reflects the company's ability to expand its market share and drive sales, which is vital for long-term success.

N/A

1 more metrics, Wall Street expectations, options signals, track record, and call prep available with Pro.

TMO Q2-2026 Earnings Preview

Context

Company Snapshot

Thermo Fisher Scientific Inc. is a leading provider of scientific instruments and reagents used in laboratories and research facilities. Operating in the Health Care sector, the company plays a crucial role in life sciences, supporting advancements in healthcare, pharmaceuticals, and biotechnology.

Earnings Scorecard·Last 8Q

EPS Beat Streak

EPS Beat Rate

100%

Avg EPS Surprise

+3.04%

Avg Stock Reaction

+0.93%

Last Quarter Recap

In Q1-2026, Thermo Fisher reported an EPS of $5.44, surpassing estimates by 4.68%. However, the stock dropped 9.20% the following day, indicating market concerns despite the earnings beat.

Management Promises & Guidance

Expectations

Wall Street Expectations

Overall, expectations are mixed as the company has consistently beaten EPS estimates but has faced stock price declines post-earnings. Investors are looking for clarity on revenue growth and margin stability.

Bull Case

If Thermo Fisher continues its trend of beating EPS estimates and shows strong revenue growth, it could signal robust demand for its products, leading to a positive stock reaction.

Bear Case

Conversely, if the company fails to meet revenue expectations or shows signs of margin compression, it could lead to further stock declines, especially given the recent history of post-earnings drops.

Expectations

Two Questions That Matter

The print will turn on these two things.

What will be the reported revenue growth rate for Q2-2026?

Revenue growth is critical for assessing the company's market position and demand for its products, which investors will closely scrutinize.

How is the gross margin expected to trend in this quarter?

Understanding gross margin trends will provide insights into cost management and pricing strategies, which are essential for profitability.

Edge

What the Street Is Missing

Why consensus could be wrong

The market may be underestimating the company's ability to maintain strong margins despite potential cost pressures, as historical performance shows resilience.

Supporting Evidence

Thermo Fisher has consistently beaten EPS estimates, indicating strong operational execution.

The options market is pricing a larger move than historical averages, suggesting that traders expect significant news.

The company has a strong track record of recovering from short-term setbacks, which may not be fully reflected in current valuations.

Key Risk

If revenue growth comes in below 5%, it could challenge the current bullish sentiment.

Edge

Thesis-Break Levels

Pre-commit to what would confirm each case.

This quarter's focus is on revenue growth and margin stability, which are pivotal for the company's future performance.

Bull Confirmed If

A revenue growth rate of 10% or higher would confirm strong demand and support the bull case.

Bear Confirmed If

A revenue growth rate below 5% would raise concerns about market demand and confirm the bear case.

Pre-Earnings Positioning

Options Market

Implied Move

±14.5%

Historical Avg

±4.5%

Pricing rich

The options market is pricing in a significant move of approximately 14.5%, indicating heightened uncertainty around the earnings report.

Options are pricing ±14.5% while TMO has averaged ±4.5% over the last 8 prints — setup is pricing rich.

Detail

ATM IV

0.3%

30d HV

41.3%

Calls (221K)P/C Ratio: 0.37Puts (485K)

Preparation

Post-Print Playbook

Likely market behavior by outcome — not investment advice.

Beat & Raise

If Thermo Fisher beats expectations, history suggests a potential stock increase of around 0.93%, confirming strong demand.

In-Line / Cautious

An in-line report may lead to muted reactions as investors await further guidance, reflecting uncertainty.

Miss

If the company misses expectations, history suggests a potential decline, anchoring around the average post-miss reaction.

Earnings Track Record

Preparation

What to Listen For

Call Prep

1Any updates on new product launches and their expected impact on revenue.
2Insights into customer demand trends in key markets.
3Management's commentary on cost pressures and margin outlook.
4Details on any strategic partnerships or acquisitions.
5Guidance on future earnings expectations and market conditions.

See the full picture

AI-powered briefs, options data, and 20 quarters of history — everything you need before earnings.

No charge today · Auto-bills $8/mo after 7 days · Cancel anytime

More Earnings This Week

5 Reports

Domino's Pizza, Inc.

Company Snapshot

Thermo Fisher Scientific Inc. is a leading provider of scientific instruments and reagents used in laboratories and research facilities....

Key Metrics to Watch

Earnings Per Share (EPS)

EPS is a key indicator of profitability and will show how well the company is managing its costs and generating income.

N/A

Revenue Growth

Revenue growth reflects the company's ability to expand its market share and drive sales, which is vital for long-term success.

N/A

1 more metrics, Wall Street expectations, options signals, track record, and call prep available with Pro.

TMO Q2-2026 Earnings Preview

Context

Company Snapshot

Earnings Scorecard·Last 8Q

EPS Beat Streak

EPS Beat Rate

100%

Avg EPS Surprise

+3.04%

Avg Stock Reaction

+0.93%

Last Quarter Recap

In Q1-2026, Thermo Fisher reported an EPS of $5.44, surpassing estimates by 4.68%. However, the stock dropped 9.20% the following day, indicating market concerns despite the earnings beat.

Management Promises & Guidance

Expectations

Wall Street Expectations

Bull Case

If Thermo Fisher continues its trend of beating EPS estimates and shows strong revenue growth, it could signal robust demand for its products, leading to a positive stock reaction.

Bear Case

Expectations

Two Questions That Matter

The print will turn on these two things.

What will be the reported revenue growth rate for Q2-2026?

Revenue growth is critical for assessing the company's market position and demand for its products, which investors will closely scrutinize.

How is the gross margin expected to trend in this quarter?

Understanding gross margin trends will provide insights into cost management and pricing strategies, which are essential for profitability.

Edge

What the Street Is Missing

Why consensus could be wrong

The market may be underestimating the company's ability to maintain strong margins despite potential cost pressures, as historical performance shows resilience.

Supporting Evidence

Thermo Fisher has consistently beaten EPS estimates, indicating strong operational execution.

The options market is pricing a larger move than historical averages, suggesting that traders expect significant news.

The company has a strong track record of recovering from short-term setbacks, which may not be fully reflected in current valuations.

Key Risk

If revenue growth comes in below 5%, it could challenge the current bullish sentiment.

Edge

Thesis-Break Levels

Pre-commit to what would confirm each case.

This quarter's focus is on revenue growth and margin stability, which are pivotal for the company's future performance.

Bull Confirmed If

A revenue growth rate of 10% or higher would confirm strong demand and support the bull case.

Bear Confirmed If

A revenue growth rate below 5% would raise concerns about market demand and confirm the bear case.

Pre-Earnings Positioning

Options Market

Implied Move

±14.5%

Historical Avg

±4.5%

Pricing rich

The options market is pricing in a significant move of approximately 14.5%, indicating heightened uncertainty around the earnings report.

Options are pricing ±14.5% while TMO has averaged ±4.5% over the last 8 prints — setup is pricing rich.

Detail

ATM IV

0.3%

30d HV

41.3%

Calls (221K)P/C Ratio: 0.37Puts (485K)

Preparation

Post-Print Playbook

Likely market behavior by outcome — not investment advice.

Beat & Raise

If Thermo Fisher beats expectations, history suggests a potential stock increase of around 0.93%, confirming strong demand.

In-Line / Cautious

An in-line report may lead to muted reactions as investors await further guidance, reflecting uncertainty.

Miss

If the company misses expectations, history suggests a potential decline, anchoring around the average post-miss reaction.

Earnings Track Record

Preparation

What to Listen For

Call Prep

1Any updates on new product launches and their expected impact on revenue.
2Insights into customer demand trends in key markets.
3Management's commentary on cost pressures and margin outlook.
4Details on any strategic partnerships or acquisitions.
5Guidance on future earnings expectations and market conditions.